Candida auris Spreads Across the US: What You Need to Know
In 2026, the potentially deadly fungus Candida auris has made headlines across the United States, with cases detected in at least 27 states, according to the Centers for Disease Control and Prevention (CDC). As of late July, there have been 3,437 reported cases, and the fungus has now spread to every major region of the country. While the overall number of infections remains relatively rare, the rising annual case count is a growing concern for health authorities.
The primary worry stems from two factors: Candida auris is largely drug-resistant, and it thrives in healthcare settings, where patients are often already vulnerable. The fungus can cause severe bloodstream infections, wound infections, and ear infections, and some strains are resistant to multiple antifungal medications, making treatment difficult. Moreover, Candida auris can persist on a patient’s skin or body for long periods, even without symptoms, allowing it to spread silently to others.
Health officials emphasize that rapid detection, screening programs, and strict infection-control measures in hospitals and long-term care facilities are crucial to preventing further spread. Major risk factors include the use of breathing tubes, feeding tubes, and catheters, which are common in patients who are already in poor health. Michigan has reported the second-highest number of cases, with 503 infections, making it a significant hotspot.
First identified in the US in 2016, Candida auris has become a public health priority. While the fungus primarily affects those in medical settings, its drug resistance and ability to spread make it a formidable challenge. Continued vigilance, improved screening, and adherence to infection control protocols are essential to curb its impact.
Shimanta Das 
